Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Evaluation of Safety and Efficacy of Using Imagine™ Computerized Radiofrequency System for Skin Tightening

This study has been completed.
Information provided by:
Endymion Medical Ltd Identifier:
First received: July 23, 2009
Last updated: NA
Last verified: July 2009
History: No changes posted

Skin aging is a multifactorial process involving the 3 layers of the skin: Epidermis, dermis and hypodermis. Skin aging process involves among others: skin roughness (epidermis), skin dyschromia (epidermis, dermis), wrinkles and elastosis - skin texture changes due to collagen modification, skin laxity and cellulite (dermis and hypodermis).

EndyMion has developed the Imagine™ system - Computerized Radiofrequency System for Skin Tightening. By using a multielectrodes treatment tip an exact computerized thermal pattern can be produced allowing to selectively heating one or more of the target tissues (epidermis, dermis and hypodermis). In the skin tightening module the dermis and hypodermis would be targeted, creating enough thermal effect to induce collagen remodeling with no ablative thermal damage in the epidermis or dermis. This post marketing study is intended for evaluation of safety and efficacy of the Imagine™ system.

Condition Intervention
Skin Aging
Skin Wrinkling
Device: Endymion Imagine™ System for Skin Tightening

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Evaluation of Safety and Efficacy of Using Imagine™ Computerized Radiofrequency System for Skin Tightening

Resource links provided by NLM:

Further study details as provided by Endymion Medical Ltd:

Primary Outcome Measures:
  • The safety of using the Imagine™ System for skin tightening will be established by physician's assessment/observation of adverse events (signs of pain, skin texture alterations or burn). [ Time Frame: 3 months ]

Secondary Outcome Measures:
  • Efficacy endpoint of using the Imagine™ System for skin tightening will be established by level of skin tightness improvement. [ Time Frame: 3 months ]

Enrollment: 30
Study Start Date: July 2008
Study Completion Date: July 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Endymion study group Device: Endymion Imagine™ System for Skin Tightening

Based on patient skin type and area of treatment the physician will choose the following parameters (some parameters are fixed):

  • Pulse energy (J);
  • RF frequency (1MHz);
  • Pulse duration (30 sec);
  • Treatment hand piece (skin tightening);


Ages Eligible for Study:   30 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy males and females age 30 and up
  • Subjects with Fitzpatrick 4 to 9 degrees of elastosis
  • Subject able to comprehend and give informed consent for participation in this study
  • Subject must commit to all treatments and follow-up visits
  • Subject must sign the Informed Consent Form

Exclusion Criteria:

  • Subjects with implanted pacemakers, arrhythmias or any other severe known heart disorder
  • Subjects with any implantable metal device in the treatment area
  • Subjects on any medication that would affect the characteristic of the skin (medical or hormonal), such as "Accutane", within the past 6 months
  • Subjects that have had any other invasive or non invasive method of skin therapy or hair removal performed in the past 6 months (in the treated area)
  • Subjects who are scheduled or planned for any other invasive or non invasive method of skin therapy or hair removal in the treatment area at the period of the study
  • Subjects who have any form of suspicious lesion on the treatment area
  • Subjects with history of keloid formations or hypertrophic scarring
  • Pregnant or lactating Subjects
  • Subjects with Epilepsy or severe migraines
  • Subjects with permanent makeup/ tattoo/ body piercing (in the treated area)
  • Subjects with any Infection / abscess / pains in treatment target area
  • Eczema or dermatitis
  • Subjects who suffer from autoimmune disorders or diabetes
  • Subjects using blood thinning medications
  • Subjects with clotting disorders
  • Subjects on drugs or psychologically determined unsuitable for the study
  • Subject is suffering extreme general weakness
  • Subject objects to the study protocol
  • Concurrent participation in any other clinical study
  • Physician objection
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00945685

Elman Clinique
Rishon Le Zion, Israel
Sponsors and Collaborators
Endymion Medical Ltd
Study Director: Varda Godfried, Dr. Endymion Medical Ltd
  More Information

Responsible Party: Dr. Hanna Levy, Endymion Medical Ltd Identifier: NCT00945685     History of Changes
Other Study ID Numbers: EN-IOP - 01
Study First Received: July 23, 2009
Last Updated: July 23, 2009

Keywords provided by Endymion Medical Ltd:
Skin Aging
Skin Wrinkling processed this record on May 22, 2017